Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Urologic Endoscopic Procedure: Cystoscopic Examination01:28

Urologic Endoscopic Procedure: Cystoscopic Examination

Meaning of Cystoscopic Examination:Cystoscopy is an essential diagnostic tool in urology that is used to assess the structure and function of the genitourinary system. It provides a direct view of the urethra, bladder, and, in some cases, the ureteral openings. This procedure helps detect structural abnormalities, infections, cancers, and blockages in the urinary tract. There are two types of cystoscopy:Flexible cystoscopy is commonly performed in outpatient settings due to its less invasive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engaging leadership and nurses' mental health in German acute care hospitals: the mediating role of job resources.

BMC nursing·2026
Same author

[Formation of disease- and needs-related homogeneous groups of insured persons - PopGrouper 1.0].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2026
Same author

Regional variation in healthcare utilization among patients with depression in Germany: a multilevel analysis with PopGrouper-based multimorbidity adjustment.

Research in health services & regions·2026
Same author

Cost-effectiveness of prehabilitation for elderly (pre-)frail patients prior to elective surgery compared to standard care - an economic evaluation from a societal perspective.

BMC medicine·2026
Same author

West African Policy Dialogue-impulse for better data: progress towards better analytics and better decisions.

BMC proceedings·2026
Same author

Germany's 2024 Hospital Transparency Act: A step towards enhanced accountability and quality in healthcare?

Health policy (Amsterdam, Netherlands)·2026
Same journal

Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country.

GMS health technology assessment·2019
Same journal

Q-SEA - a tool for quality assessment of ethics analyses conducted as part of health technology assessments.

GMS health technology assessment·2017
Same journal

Effects of continuous and intermittent renal replacement therapies among adult patients with acute kidney injury.

GMS health technology assessment·2017
Same journal

Telemedicine: The legal framework (or the lack of it) in Europe.

GMS health technology assessment·2016
Same journal

Complex health care interventions: Characteristics relevant for ethical analysis in health technology assessment.

GMS health technology assessment·2016
Same journal

Electronic health records: Is it a risk worth taking in healthcare delivery?

GMS health technology assessment·2015
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Screening on urogenital Chlamydia trachomatis.

Helena de Carvalho Gomes1, Marcial Velasco-Garrido, Reinhard Busse

  • 1Technische Universität Berlin, Fachgebiet Management im Gesundheitswesen, Berlin, Deutschland.

GMS Health Technology Assessment
|February 4, 2011
PubMed
Summary
This summary is machine-generated.

Screening for Chlamydia trachomatis in Germany is partially supported by evidence. Further research on acceptance and cost-effectiveness is needed before inclusion in the national health benefit basket.

Keywords:
chlamydia trachomatis infectioninfectionmass screeningscreening programmeurethritis

More Related Videos

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

Related Experiment Videos

Last Updated: Jun 4, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

Area of Science:

  • Public Health
  • Infectious Diseases
  • Screening Programs

Background:

  • Chlamydia trachomatis causes 92 million yearly urogenital infections globally.
  • Rising incidence of sexually transmitted diseases necessitates early diagnosis and therapy.
  • Chlamydia trachomatis infections lead to severe health issues in women, men, and newborns.

Purpose of the Study:

  • To evaluate evidence for including Chlamydia trachomatis screening in the German health benefit basket.
  • To summarize available evidence on Chlamydia trachomatis screening.

Main Methods:

  • Systematic review of Health Technology Assessment (HTA) reports, systematic reviews, guidelines, and primary research.
  • Synthesis based on Wilson and Jungner's screening criteria: relevance, test availability, effectiveness, acceptance, and economics.
  • Literature search and evidence summarization in tables.

Main Results:

  • Identified 5 HTA reports and 5 guidelines from Europe and North America.
  • Included 56 primary research publications covering disease relevance, test availability, screening effectiveness, program acceptance, and economic issues.
  • Evidence suggests screening criteria are partially met, with success dependent on uptake enhancement strategies and male participation.

Conclusions:

  • Fulfilment of screening criteria depends on contextual factors, with a need for more Germany-specific data.
  • A pilot project is recommended to assess cost-effectiveness, acceptance, and feasibility of screening strategies in Germany.
  • Inclusion in the benefit basket is not recommended without a multifaceted program for primary prevention and participation enhancement.